Effectiveness of Golimumab in Clinical Management of Patients with Rheumatoid Arthritis

摘要

Background and Objectives Limited data are available regarding the use of golimumab (100mg) every 4weeks, with or without methotrexate (MTX). The aim of this retrospective analysis was to evaluate the effectiveness and safety of golimumab following usual clinical practice in Japanese patients with rheumatoid arthritis (RA) according to the recommendations given in the Japanese package insert.